Suppressive effects of isorhynchophylline on 5-HT2A receptor function in the brain: Behavioural and electrophysiological studies

European Journal of Pharmacology

Volumn 517, Issue 3, 2005, Pages 191-199

  Matsumoto, Kinzo ^a   Morishige, Ryo ^a   Murakami, Yukihisa ^a   Tohda, Michihisa ^a   Takayama, Hiromitsu ^b   Sakakibara, Iwao ^c   Watanabe, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c TSUMURA AND CO   (Japan)

Author keywords

5 HT2A receptor mediated current response; 5 HT2A receptor mediated head twitch response; Isocorynoxeine; Isorhynchophylline; Uncaria alkaloid; Xenopus oocyte

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 5 METHOXY N,N DIMETHYLTRYPTAMINE; ALKALOID DERIVATIVE; CORYNOXEINE; ISOCORYNOXEINE; ISORHYNCHOPHYLLINE; OXINDOLE; RESERPINE; RHYNCHOPHYLLINE; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; DOSE RESPONSE; DRUG EFFECT; ELECTROPHYSIOLOGY; LOCOMOTION; MALE; MONOAMINE METABOLISM; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; STEREOISOMERISM; XENOPUS;

ALKALOIDS; AMINOPYRIDINES; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INDOLE ALKALOIDS; KETANSERIN; MALE; MEMBRANE POTENTIALS; METHOXYDIMETHYLTRYPTAMINES; MIANSERIN; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; OOCYTES; PATCH-CLAMP TECHNIQUES; PIPERAZINES; RATS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN; SEROTONIN ANTAGONISTS; XENOPUS;

EID: 22144439745     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.05.015     Document Type: Article

References (30)

1. A.-F. Abdel-fattah Mohamed, K. Matsumoto, K. Tabata, H. Takayama, M. Kitajima, N. Aimi, and H. Watanabe Effects of Uncaria tomentosa total alkaloid and its components on experimental amnesia in mice: elucidation using the passive avoidance test Journal of Pharmacy and Pharmacology 52 2000 1553 1561
2. G.K. Aghajanian, and G.J. Marek Serotonin model of schizophrenia: emerging role of glutamate mechanisms Brain Research Reviews 31 2000 302 312
3. 1A receptors Pharmacology, Biochemistry and Behavior 57 1997 301 307
4. 2 receptor mechanism in the REM sleep deprivation-induced increase in swimming activity in the forced swimming test Pharmacology, Biochemistry and Behavior 48 1994 43 46
5. 2 receptor subtypes: a family re-united? Trends in Pharmacological Sciences 16 1995 105 110
6. 1A receptors Pharmacology, Biochemistry and Behavior 38 1991 353 357
7. 2C receptors in mice European Journal of Pharmacology 341 1998 135 138
8. 2B receptors Behavioral Pharmacology 12 2001 613 620
9. 2 agonists or antagonists? Naunyn-Schmiedeberg's Archives of Pharmacology 337 1990 255 260
10. A.R. Green, and D.J. Heal The effects of drugs on serotonin-mediated behavioural models A.R. Green Neuropharmacology of Serotonin 1985 Oxford University Press Oxford 326 363
11. 2C receptor antagonists Journal of Biological Chemistry 271 1996 22591 22597
12. 2-mediated head-twitch responses in mice: possible implications for the actions of antidepressant drugs Psychopharmacology (Berl) 89 1986 414 420
13. 2A receptor antagonist M100,907 attenuates motor and impulsive-type' behaviours produced by NMDA receptor antagonism Psychopharmacology 170 2003 309 319
14. 1 acetylcholine receptors expressed in Xenopus oocytes Japanese Journal of Pharmacology 88 2002 210 pp
15. 2 receptors in Xenopus oocyte expressing rat cortex total RNA European Journal of Pharmacology 444 2002 44 50
16. T.-H. Kang, Y. Murakami, K. Matsumoto, H. Takayama, M. Kitajima, N. Aimi, and H. Watanabe Rhynchophylline and isorhynchophylline inhibit NMDA receptors expressed in Xenopus oocytes European Journal of Pharmacology 455 2002 27 34
17. H.S. Kim, I.S. Park, H.K. Lim, H.S. Choi, S. Oh, W.K. Park, C.G. Jang, S.H. Kim, and M.J. Chang N-Methyl-D-aspartate receptor antagonists enhance the head-twitch response, a 5-hydroxytryptamine2 receptor-mediated behaviour, in reserpine-treated mice Journal of Pharmacy and Pharmacology 52 2000 717 722
18. 1A receptor antagonist: p-MPPI Life Sciences 55 1994 1459 1462
19. 1A sites in rat brain: in vitro binding and autoradiographic studies Journal of Pharmacology and Experimental Therapeutics 272 1995 429 437
20. J. Labrecque, A. Fargin, M. Bouvier, P. Chidiac, and M. Dennis Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells Molecular Pharmacology 48 1995 150 159
21. I. Lucki, H.R. Ward, and A. Frazer Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity Journal of Pharmacology and Experimental Therapeutics 249 1989 155 164
22. K. Matsumoto, M. Mizowaki, T. Suchitra, Y. Murakami, H. Takayama, S.-I. Sakai, N. Aimi, and H. Watanabe Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems European Journal of Pharmacology 317 1996 75 81
23. K. Matsumoto, M. Mizowaki, H. Takayama, S.-I. Sakai, N. Aimi, and H. Watanabe Suppressive effect of mitragynine on the 5-methoxy-N,N- dimethyltryptamine-induced head-twitch response in mice Pharmacology, Biochemistry and Behavior 57 1997 319 323
24. 2 receptor antagonist suppression of head-twitch behavior in mice Pharmacology, Biochemistry and Behavior 56 1997 417 422
25. H.Y. Meltzer, Z. Li, Y. Kaneda, and J. Ichikawa Serotonin receptors: their key roles in drugs to treat schizophrenia Progress in Neuro- Psychopharmacology & Biological Psychiatry 27 2003 1159 1172
26. 2 agonist-induced Arc gene expression in the rat cortex Neuropharmacology 46 2004 331 339
27. 2A receptor-mediated cGMP formation: the essential role of glutamate Brain Research 1003 2004 168 175
28. 2A receptors in antipsychotic activity Life Sciences 56 1995 2209 2222
29. W. Tang, and G. Eisenbrand Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine 1992 Springer-Verlag Berlin 1056
30. K. Terasawa, Y. Shimada, T. Kita, T. Yamamoto, H. Tosa, N. Tanaka, Y. Saito, E. Kanaki, S. Goto, N. Mizusima, M. Fujioka, S. Takase, H. Seki, I. Kimura, T. Ogawa, S. Nakamura, G. Araki, I. Maruyama, Y. Maruyama, and S. Takaori Choto-san in the treatment of vascular dementia: a double-blind, placebo-controlled study Phytomedicine 4 1997 15 22